Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Martens, John W. M."'
Autor:
Verschoor N; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. n.verschoor@erasmusmc.nl., Bos MK; Department of Internal Medicine, Breast Cancer Center South Holland South, Ikazia Hospital, Rotterdam, The Netherlands., de Kruijff IE; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Van MN; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Drooger JC; Department of Internal Medicine, Breast Cancer Center South Holland South, Ikazia Hospital, Rotterdam, The Netherlands., Zuetenhorst JM; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, The Netherlands., Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 May; Vol. 205 (1), pp. 87-95. Date of Electronic Publication: 2024 Jan 31.
Autor:
Stevens M; Department of Medical Cell BioPhysics, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands., Mentink A; Department of Medical Cell BioPhysics, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands., Nanou A; Department of Medical Cell BioPhysics, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands., Coumans FAW; Department of Medical Cell BioPhysics, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands., Isebia KT; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hamberg P; Department of Oncology, Franciscus Gasthuis & Vlietland Hospital, Schiedam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Terstappen LWMM; Department of Medical Cell BioPhysics, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands.
Publikováno v:
Cytometry. Part A : the journal of the International Society for Analytical Cytology [Cytometry A] 2023 Nov; Vol. 103 (11), pp. 881-888. Date of Electronic Publication: 2023 Aug 02.
Autor:
Isebia KT; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Mostert B; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Deger T; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., de Weerd V; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, The Netherlands., Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, Rotterdam, The Netherlands., Helgason HH; Department of Medical Oncology, Haaglanden Medical Centre, The Hague, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., van Riet J; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
Publikováno v:
Molecular oncology [Mol Oncol] 2023 Sep; Vol. 17 (9), pp. 1898-1907. Date of Electronic Publication: 2023 Aug 18.
Autor:
Isebia KT; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Mostert B; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Belderbos BPS; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Buck SAJ; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Helmijr JCA; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Kraan J; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Beaufort CM; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Van MN; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Oomen-de Hoop E; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Sieuwerts AM; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., van IJcken WFJ; Center for Biomics, Erasmus University Medical Center, Rotterdam, the Netherlands., van den Hout-van Vroonhoven MCGN; Center for Biomics, Erasmus University Medical Center, Rotterdam, the Netherlands., Brouwer RWW; Center for Biomics, Erasmus University Medical Center, Rotterdam, the Netherlands., Oole E; Center for Biomics, Erasmus University Medical Center, Rotterdam, the Netherlands., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/ Schiedam, the Netherlands., Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, Rotterdam, the Netherlands., Helgason HH; Department of Medical Oncology, Haaglanden Medical Centre, The Hague, the Netherlands., de Wit R; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Sleijfer S; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Mathijssen RHJ; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Martens JWM; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Jansen MPHM; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., van Riet J; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Lolkema MP; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands. Electronic address: m.lolkema@erasmusmc.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Dec; Vol. 177, pp. 33-44. Date of Electronic Publication: 2022 Oct 06.
Autor:
Deger T; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Mendelaar PAJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Prager-van der Smissen WJC; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van der Vlugt-Daane M; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Bindels EMJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Molecular oncology [Mol Oncol] 2022 Aug; Vol. 16 (16), pp. 2981-3000. Date of Electronic Publication: 2022 Jul 08.
Autor:
Bos MK; Manouk K. Bos, MD, Jaco Kraan, PhD, Stefan Sleijfer, MD, PhD, John W. M. Martens, PhD, and Nick Beije, MD, PhD, Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Kraan J; Manouk K. Bos, MD, Jaco Kraan, PhD, Stefan Sleijfer, MD, PhD, John W. M. Martens, PhD, and Nick Beije, MD, PhD, Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Sleijfer S; Manouk K. Bos, MD, Jaco Kraan, PhD, Stefan Sleijfer, MD, PhD, John W. M. Martens, PhD, and Nick Beije, MD, PhD, Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Martens JWM; Manouk K. Bos, MD, Jaco Kraan, PhD, Stefan Sleijfer, MD, PhD, John W. M. Martens, PhD, and Nick Beije, MD, PhD, Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Beije N; Manouk K. Bos, MD, Jaco Kraan, PhD, Stefan Sleijfer, MD, PhD, John W. M. Martens, PhD, and Nick Beije, MD, PhD, Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Feb 10; Vol. 40 (5), pp. 519-520. Date of Electronic Publication: 2021 Dec 08.
Autor:
Mout L; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., van Dessel LF; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., de Jong AC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Neves RPL; Department of General, Visceral and Pediatric Surgery, Heinrich-Heine University, University Hospital Düsseldorf, Düsseldorf, Germany., Erkens-Schulze S; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Beaufort CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., van Riet J; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Woo TLC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands., Sandberg Y; Department of Internal Medicine, Maasstad Hospital, Rotterdam, the Netherlands., Te Boekhorst PAW; Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., van de Werken HJG; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Stoecklein NH; Department of General, Visceral and Pediatric Surgery, Heinrich-Heine University, University Hospital Düsseldorf, Düsseldorf, Germany., van Weerden WM; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: m.lolkema@erasmusmc.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Jun; Vol. 150, pp. 179-189. Date of Electronic Publication: 2021 Apr 28.
Autor:
Mendelaar PAJ; Department of Medical Oncology, Erasmus MC University Medical Center, Cancer Institute, Rotterdam, The Netherlands., Kraan J; Department of Medical Oncology, Erasmus MC University Medical Center, Cancer Institute, Rotterdam, The Netherlands., Van M; Department of Medical Oncology, Erasmus MC University Medical Center, Cancer Institute, Rotterdam, The Netherlands., Zeune LL; Department of Medical Cell BioPhysics, University of Twente, Enschede, The Netherlands., Terstappen LWMM; Department of Medical Cell BioPhysics, University of Twente, Enschede, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC University Medical Center, Cancer Institute, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC University Medical Center, Cancer Institute, Rotterdam, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC University Medical Center, Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Molecular oncology [Mol Oncol] 2021 Jan; Vol. 15 (1), pp. 116-125. Date of Electronic Publication: 2020 Oct 04.
Autor:
van Dessel LF; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., Martens JWM, Lolkema MP
Publikováno v:
Current opinion in oncology [Curr Opin Oncol] 2020 Sep; Vol. 32 (5), pp. 527-534.
Autor:
de Kruijff IE; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Onstenk W; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hamberg P; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., de Jongh FE; Department of Medical Oncology, Ikazia Ziekenhuis, Rotterdam, The Netherlands., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Timmermans MA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2019 Aug 15; Vol. 145 (4), pp. 1083-1089. Date of Electronic Publication: 2019 Feb 27.